ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,219.94
-0.03%
Dow Jones
39,395.01
-0.09%
US Dollar vs MXN
16.8417
0.26%
Brent Oil
82.205
-1.21%
Bitcoin
61,366.50
-2.44%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Noticias

AMGN

Amgen (AMGN)

Amgen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AMGN
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMGNAmgen Inc
09/05/202418:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
09/05/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
03/05/202408:12IH Market NewsAmgen, Bock Up; Cloudflare, Expedia WeakNASDAQ:AMGNAmgen Inc
02/05/202415:01PR Newswire (US)AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
01/05/202406:00PR Newswire (US)AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024NASDAQ:AMGNAmgen Inc
29/04/202415:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
26/04/202408:00PR Newswire (US)AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCYNASDAQ:AMGNAmgen Inc
16/04/202416:26PR Newswire (US)AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024NASDAQ:AMGNAmgen Inc
09/03/202411:20PR Newswire (US)AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024NASDAQ:AMGNAmgen Inc
06/03/202415:00PR Newswire (US)AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
29/02/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCENASDAQ:AMGNAmgen Inc
26/02/202408:00PR Newswire (US)AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIONASDAQ:AMGNAmgen Inc
19/02/202415:00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL ON RARE DISEASENASDAQ:AMGNAmgen Inc
14/02/202415:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMGNAmgen Inc
09/02/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCENASDAQ:AMGNAmgen Inc
07/02/202404:49IH Market NewsMoody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market UpdatesNASDAQ:AMGNAmgen Inc
06/02/202416:05IH Market NewsU.S. Stocks Finish Choppy Trading Day Modestly HigherNASDAQ:AMGNAmgen Inc
06/02/202415:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
06/02/202415:01PR Newswire (US)AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/02/202405:27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNASDAQ:AMGNAmgen Inc
02/02/202415:25IH Market NewsU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon ResultsNASDAQ:AMGNAmgen Inc
01/02/202415:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
29/01/202404:00PR Newswire (Canada)deCODE genetics: A sequence variant that increases risk of pregnancy lossNASDAQ:AMGNAmgen Inc
17/01/202405:33IH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNASDAQ:AMGNAmgen Inc
10/01/202409:12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:AMGNAmgen Inc
10/01/202407:53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:AMGNAmgen Inc
10/01/202407:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNASDAQ:AMGNAmgen Inc
03/01/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
02/01/202410:42Dow Jones NewsAmgen On Pace for Record High Close -- Data TalkNASDAQ:AMGNAmgen Inc
 Showing the most relevant articles for your search:NASDAQ:AMGN

Su Consulta Reciente

AMEX
XLE
Energy Select Sector SPDR
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
NYSE
XOM
Exxon Mobil
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
CCOM
OILBRENT
Brent Oil
NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados